Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates-Reference-Cited by-同舟云学术

Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates

Published:2022-12-10 Issue: Volume: Page:
ISSN:0301-486X
Container-title:Mycopathologia
language:en
Short-container-title:Mycopathologia

Author:

Yazdanpanah Somayeh,Ahmadi Mohammad,Zare Zahra,Nikoupour Hamed,Arabsheybani Sara,Jabrodini Ahmad,Eghtedarnejad Esmaeel,Chamanpara Parisa,Geramizadeh Bita,Anbardar Mohammad Hossein,Malekizadeh Zahra,Gashtasebi Maryam,Mohsenzadeh Mehdi,Shafiekhani Mojtaba,Zomorodian Kamiar

Funder

Vice-Chancellor for Research, Shiraz University of Medical Sciences

Publisher

Springer Science and Business Media LLC

Subject

Veterinary (miscellaneous),Agronomy and Crop Science,Applied Microbiology and Biotechnology,Microbiology

Link

https://link.springer.com/content/pdf/10.1007/s11046-022-00694-x.pdf

Reference69 articles.

1. Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62.

2. Silva DL, et al. Fungal and bacterial coinfections increase mortality of severely ill COVID-19 patients. J Hosp Infect. 2021;113:145–54.

3. Shafiekhani M, et al. Bacterial and fungal co-infections with SARS-CoV-2 in solid organ recipients: a retrospective study. Virol J. 2022;19(1):1–7.